MX2021014842A - Sales cristalinas no higroscopicas de un compuesto de pirazol y composiciones farmaceuticas y uso de las mismas. - Google Patents

Sales cristalinas no higroscopicas de un compuesto de pirazol y composiciones farmaceuticas y uso de las mismas.

Info

Publication number
MX2021014842A
MX2021014842A MX2021014842A MX2021014842A MX2021014842A MX 2021014842 A MX2021014842 A MX 2021014842A MX 2021014842 A MX2021014842 A MX 2021014842A MX 2021014842 A MX2021014842 A MX 2021014842A MX 2021014842 A MX2021014842 A MX 2021014842A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
crystalline salts
pyrazole compound
hygroscopic crystalline
hygroscopic
Prior art date
Application number
MX2021014842A
Other languages
English (en)
Spanish (es)
Inventor
Robert Sullivan
Original Assignee
Biotheryx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotheryx Inc filed Critical Biotheryx Inc
Publication of MX2021014842A publication Critical patent/MX2021014842A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2021014842A 2019-06-03 2020-06-02 Sales cristalinas no higroscopicas de un compuesto de pirazol y composiciones farmaceuticas y uso de las mismas. MX2021014842A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962856605P 2019-06-03 2019-06-03
PCT/US2020/035654 WO2020247345A1 (en) 2019-06-03 2020-06-02 Non-hygroscopic crystalline salts of a pyrazole compound, and pharmaceutical compositions and use thereof

Publications (1)

Publication Number Publication Date
MX2021014842A true MX2021014842A (es) 2022-02-21

Family

ID=71787173

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014842A MX2021014842A (es) 2019-06-03 2020-06-02 Sales cristalinas no higroscopicas de un compuesto de pirazol y composiciones farmaceuticas y uso de las mismas.

Country Status (14)

Country Link
US (1) US12428399B2 (cg-RX-API-DMAC7.html)
EP (1) EP3976600B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022535850A (cg-RX-API-DMAC7.html)
KR (1) KR20220041050A (cg-RX-API-DMAC7.html)
CN (1) CN114423752B (cg-RX-API-DMAC7.html)
AU (1) AU2020288163B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021024330A2 (cg-RX-API-DMAC7.html)
CA (1) CA3142271A1 (cg-RX-API-DMAC7.html)
ES (1) ES3071437T3 (cg-RX-API-DMAC7.html)
IL (1) IL288547B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021014842A (cg-RX-API-DMAC7.html)
SG (1) SG11202113211PA (cg-RX-API-DMAC7.html)
TW (1) TWI866977B (cg-RX-API-DMAC7.html)
WO (1) WO2020247345A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021209057A1 (en) * 2020-01-13 2022-06-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Pyrazolylpyrimidines and use thereof
US20240207268A1 (en) * 2021-03-24 2024-06-27 Biotheryx, Inc. Pyrazolylpyrimidines for treating malignant solid tumor
US20230053307A1 (en) * 2021-07-19 2023-02-16 Buddhist Tzu Chi Medical Foundation Method for preventing or treating skin disorders and conditions
WO2025199440A1 (en) * 2024-03-21 2025-09-25 Edgewood Oncology Methods of treating liposarcoma using a pyrazole compound

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637809A (en) 1968-07-05 1972-01-25 Ciba Geigy Corp Antioxidants
US3698123A (en) 1971-12-06 1972-10-17 Carl R Heldt Structural toys
US3917899A (en) 1972-08-04 1975-11-04 Michael J Oliver Plate for adjustably mounting electrical receptacle
US3846770A (en) 1973-07-11 1974-11-05 Us Navy Serial access memory using magnetic domains in thin film strips
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
DE2839461C2 (de) 1978-09-11 1987-01-15 Bergwerksverband Gmbh, 4300 Essen Formmassen aus thermoplastischen Kunststoffen und Rückständen der Kohlehydrierung
US4328246A (en) 1979-08-14 1982-05-04 Joseph Gold Anti Walker 256 carcinoma agent and combination thereof
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US5762756A (en) 1994-11-21 1998-06-09 The Black Clawson Company Methods and apparatus for pulping and deinking
US6069696A (en) 1995-06-08 2000-05-30 Psc Scanning, Inc. Object recognition system and method
US6576139B1 (en) 1996-07-30 2003-06-10 Kenneth C. Hou Process for purifying photoresist composition employing a filter sheet
DE19630939C1 (de) 1996-07-31 1997-12-11 Siemens Ag Kontaktfeder
KR100218318B1 (ko) 1996-10-01 1999-09-01 문정환 주파수 변환장치
US7274662B1 (en) 1998-08-04 2007-09-25 At&T Corp. Method for performing segmented resource reservation
US6062668A (en) 1996-12-12 2000-05-16 Hitachi Koki Imaging Solutions, Inc. Drop detector for ink jet apparatus
US6364667B1 (en) 1997-03-14 2002-04-02 Relational Technologies Llp Techniques for mastering a body of knowledge by writing questions about the body of knowledge
US6073643A (en) 1998-09-14 2000-06-13 Patent Category Corp. Adjustable collapsible panels
US6262067B1 (en) * 1999-06-22 2001-07-17 Pfizer Inc. Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
DE20019821U1 (de) 1999-12-09 2001-06-07 BRAND GMBH + CO KG, 97877 Wertheim Dosiereinrichtung für Flüssigkeiten
EP1188148A2 (en) 2000-01-27 2002-03-20 Koninklijke Philips Electronics N.V. Method and system for extracting spine geometrical data
US6691777B2 (en) 2000-08-15 2004-02-17 Baker Hughes Incorporated Self-lubricating swage
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US6947491B2 (en) 2000-09-13 2005-09-20 Interdigital Technology Corporation Third generation FDD modem interleaver
AU2001296496A1 (en) 2000-10-02 2002-04-15 The University Of Akron Synthesis and characterization of nanocomposites by emulsion polymerization
US7113943B2 (en) 2000-12-06 2006-09-26 Content Analyst Company, Llc Method for document comparison and selection
US7120761B2 (en) 2000-12-20 2006-10-10 Fujitsu Limited Multi-port memory based on DRAM core
JP4007767B2 (ja) 2001-01-18 2007-11-14 日本碍子株式会社 圧電/電歪デバイスおよびその製造方法
US6709874B2 (en) 2001-01-24 2004-03-23 Infineon Technologies Ag Method of manufacturing a metal cap layer for preventing damascene conductive lines from oxidation
US6980946B2 (en) 2001-03-15 2005-12-27 Microsoft Corporation Method for hybrid processing of software instructions of an emulated computer system
WO2002077657A1 (en) 2001-03-22 2002-10-03 Fujitsu Limited Magnetoresistive spin-valve sensor and magnetic storage apparatus
JP4124607B2 (ja) 2001-04-06 2008-07-23 ヤマウチ株式会社 ピンチローラおよびピンチローラ装置
US6840774B2 (en) 2001-05-07 2005-01-11 Jack W. Fretwell, Jr. System to teach, measure and rate learner knowledge of basic mathematics facts
US6798220B1 (en) 2001-06-27 2004-09-28 Timothy H. Flanigan Moisture/mold detector
US6891474B1 (en) 2001-08-01 2005-05-10 Tagsense, Inc. Electromagnetic identification label for anti-counterfeiting, authentication, and tamper-protection
US7345559B2 (en) 2001-09-13 2008-03-18 General Electric Company High field open MRI magnet isolation system and method
US6965468B2 (en) 2003-07-03 2005-11-15 Reflectivity, Inc Micromirror array having reduced gap between adjacent micromirrors of the micromirror array
US7039976B2 (en) 2002-04-09 2006-05-09 Maytag Corporation Braking control system for a washing machine
US6739477B1 (en) 2002-04-12 2004-05-25 Floro Pascual Golf ball dispenser
US7048737B2 (en) 2002-06-11 2006-05-23 Bioplate, Inc. Cranial bone flap fixation system and method
WO2004001741A1 (en) 2002-06-21 2003-12-31 Seagate Technology Llc Fluid dynamic bearing asymmetry pressure feedback
DE10240053A1 (de) 2002-08-30 2004-03-11 Robert Bosch Gmbh Brückenzünder-Zündelement
US6739108B2 (en) 2002-09-30 2004-05-25 Allpax Products, Inc. Fragile container handling system for retort/sterilization processes
JP2004158619A (ja) 2002-11-06 2004-06-03 Matsushita Electric Ind Co Ltd 電子デバイスおよびその製造方法
US6712069B1 (en) 2002-11-20 2004-03-30 William L. Spangler Solar energy collection and storage system
US7139876B2 (en) 2003-01-16 2006-11-21 Ip-First, Llc Microprocessor and apparatus for performing fast speculative pop operation from a stack memory cache
ITBO20030105A1 (it) 2003-02-28 2004-09-01 Fasco Spa Pistola pneumatica per elementi di fissaggio.
US7360468B2 (en) 2003-03-19 2008-04-22 Nsk Ltd. Electric power steering device and resin gear used for the same
US7248373B2 (en) 2003-03-21 2007-07-24 Durr Systems, Inc Workpiece configuration detection system and method
US6867376B2 (en) 2003-04-17 2005-03-15 Bellsouth Intellectual Property Corporation Glow rods with externally mountable anchoring members and related methods
US7069377B2 (en) 2003-05-08 2006-06-27 Micron Technology, Inc. Scratch control memory array in a flash memory device
FR2854693B1 (fr) 2003-05-09 2005-07-01 Siemens Vdo Automotive Procede de determination de l'energie d'un signal de cliquetis pour moteur a combustion interne
WO2004112800A1 (en) 2003-06-19 2004-12-29 Bodor Nicholas S Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
US6993866B1 (en) 2003-06-25 2006-02-07 James Strange Fishing bait rig attachment apparatus with rotating rattle
US6922367B2 (en) 2003-07-09 2005-07-26 Micron Technology, Inc. Data strobe synchronization circuit and method for double data rate, multi-bit writes
JP4183181B2 (ja) 2003-08-07 2008-11-19 株式会社小松製作所 異物除去装置
DE102004027446B4 (de) 2004-06-04 2007-08-23 Jungheinrich Aktiengesellschaft Vorrichtung zur Unterstützung des Ein- und Ausstapelns bei einem Stapler
US7197360B1 (en) 2005-01-12 2007-03-27 Pacesetter, Inc. Methods and systems for using an inductor to increase capacitor reformation efficiency in an implantable cardiac device (ICD)
US7377471B1 (en) 2005-06-06 2008-05-27 Compton Harry L Method and system for opening and securing a railroad frog
US7271369B2 (en) 2005-08-26 2007-09-18 Aem, Inc. Multilayer positive temperature coefficient device and method of making the same
JP4666514B2 (ja) 2006-07-20 2011-04-06 リンテック株式会社 シート剥離装置及び剥離方法
US7799600B2 (en) 2007-05-31 2010-09-21 Chien-Min Sung Doped diamond LED devices and associated methods
US7689648B2 (en) 2007-06-27 2010-03-30 Microsoft Corporation Dynamic peer network extension bridge
IT1395963B1 (it) * 2009-06-04 2012-11-02 Rottapharm Spa Forme cristalline di 6-(1h-imidazol-1-il)-2-fenil chinazolina e dei suoi sali
US10370369B2 (en) * 2015-03-31 2019-08-06 Yuki Gosei Kogyo Co. Ltd. Acid addition salt of 3-aminoquinuclidine which does not exhibit deliquescence
RS62728B1 (sr) * 2015-08-04 2022-01-31 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Derivat pirazol pirimidina i njegove upotrebe
EP3378477A1 (en) * 2017-03-21 2018-09-26 BIOPROJET Pharma New therapeutical use of h3-ligands
KR20200130287A (ko) * 2018-02-08 2020-11-18 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 헤테로아릴 화합물, 이의 약학 조성물 및 이의 치료적 용도

Also Published As

Publication number Publication date
ES3071437T3 (es) 2026-06-23
WO2020247345A1 (en) 2020-12-10
IL288547A (en) 2022-02-01
CA3142271A1 (en) 2020-12-10
SG11202113211PA (en) 2021-12-30
EP3976600B1 (en) 2026-05-20
KR20220041050A (ko) 2022-03-31
CN114423752A (zh) 2022-04-29
JP2022535850A (ja) 2022-08-10
AU2020288163B2 (en) 2026-03-26
IL288547B1 (en) 2025-06-01
EP3976600A1 (en) 2022-04-06
US20220332702A1 (en) 2022-10-20
EP3976600C0 (en) 2026-05-20
BR112021024330A2 (pt) 2022-01-11
AU2020288163A1 (en) 2022-01-06
TW202110827A (zh) 2021-03-16
CN114423752B (zh) 2025-06-24
IL288547B2 (en) 2025-10-01
US12428399B2 (en) 2025-09-30
TWI866977B (zh) 2024-12-21

Similar Documents

Publication Publication Date Title
CL2024000532A1 (es) Compuestos y métodos para el tratamiento de infecciones virales
CO2022015638A2 (es) Compuestos, composiciones farmacéuticas y métodos para la preparación de compuestos y para su uso
CL2023003041A1 (es) Derivados de triazina que tienen actividad inhibidora de la replicación del virus y composición farmacéutica
CO2023001407A2 (es) Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y métodos de uso de los mismos
ECSP20013248A (es) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
MX2020011868A (es) Inhibidores de los receptores erbb.
EA201891315A1 (ru) Твердые дисперсии, содержащие стимулятор sgc
CL2007000601A1 (es) Compuestos derivados de heterobiciclos pirazolicos, inhibidores de la actividad de proteina tiroxina quinasa; composicion farmaceutica que comprende dichos compuestos; y uso de los compuestos en el tratamiento de una enfermedad hiperproliferativa.
EA202090413A1 (ru) Пиразоло- и триазолобициклические соединения в качестве ингибиторов jak киназы
PE20180160A1 (es) Sulfonilureas y compuestos relacionados y uso de estos
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
PE20210096A1 (es) Inhibidor de ret para uso en tratar cancer que tiene una alteracion de ret
EA201692268A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
CL2008000862A1 (es) Compuestos derivados de triazolonas, inhibidores no nucleosidos de transcriptasa inversa; composicion farmaceutica que contiene a dichos compuestos; y uso del compuesto para tratar la infeccion del vih-1.
SA522441624B1 (ar) مثبطات إنزيمات كيناز مستقبل عامل نمو الأرومة الليفية
BR112021024330A2 (pt) Sais cristalinos não higroscópicos de um composto de pirazol, e composições farmacêuticas e uso dos mesmos
CL2019002900A1 (es) Análogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton.
PH12021550687A1 (en) Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
BR112021022712A2 (pt) Formas cristalinas de n-[4-(clorodifluorometóxi)fenil]-6-[(3r)-3-hidroxipirrolidin-1-il]-5-(1h-pirazol-5-il)piridina-3-carboxamida
MX2026001845A (es) Metodos para el tratamiento de la trombocitopenia inmunitaria mediante la administracion de (r)-2-[3-[4-amino-3-(2-fluoro-4-fenoxi-fenil)pirazolo[3,4-d]pirimidin-1-il]piperidino-1-carbonil]-4-metil-4-[4-(oxetan-3-il)piperazin-1-il]pent-2-enonitrilo
CO2024009144A2 (es) Inhibidores de cinasa met
CO2024012427A2 (es) Pirimidinas para degradar la tirosina quinasa de bruton
CU20210044A7 (es) Pirazoles como moduladores de hemoglobina
UY38006A (es) Inhibidores de la quinasa mtor, composiciones farmacéuticas que los contienen, y al uso en terapia de tales compuestos y composiciones
CY1124397T1 (el) Κρυσταλλικο (2s,4r)-5-(5'-χλωρο-2-φθορο-[1,1'-διφαινυλ] -4-υλ)-2-(αιθοξυμεθυλ)-4-(3-υδροξυϊσοξαζολη-5- καρβοξαμιδο) -2-μεθυλπεντανοϊκο οξυ και χρησεις αυτου